المؤلفون: Pisana, Alice, Wettermark, Björn, Kurdi, Amanj, Tubic, Biljana, Pontes, Caridad, Zara, Corinne, Van Ganse, Eric, Petrova, Guenka, Mardare, Ileana, Fürst, Jurij, Roig-Izquierdo, Marta, Melien, Oyvind, Bonanno, Patricia Vella, Banzi, Rita, Markovic-Pekovic, Vanda, Mitkova, Zornitsa, Godman, Brian

المصدر: Frontiers in Pharmacology. 13

مصطلحات موضوعية: new cancer medicines, patient-level datasets, pricing and reimbursement, funding concerns, pharmaceutical policy, cross-national collaboration, european countries

وصف الملف: electronic

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-481191
https://doi.org/10.3389/fphar.2022.873556
https://uu.diva-portal.org/smash/get/diva2:1686056/FULLTEXT01.pdf

المؤلفون: Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman

المصدر: Frontiers in pharmacology, Lausanne : Frontiers Media S.A., 2022, vol. 13, art. no. 873556, p. [1-16]

مصطلحات موضوعية: Pharmacology, Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi, Pharmaceutical policy -- European Union countries, pharmaceutical policy, new cancer medicines, Cancer -- Treatment -- Costs, Health Care Service and Management, Health Policy and Services and Health Economy, Finance -- European Union countries, funding concerns, Medical care, Cost of -- European Union countries, Hospitals -- Prospective payment, RS, cross-national collaboration, European countries, patient-level datasets, pricing and reimbursement, european countries, Pharmacology (medical)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7372c36fdc29e8cd548caaf609004ddd
https://strathprints.strath.ac.uk/80875/7/Pisana_etal_FIP_2022_Challenges_and_opportunities_with_routinely_collected_data.pdf

المؤلفون: Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, new cancer medicines, patient-level datasets, pricing and reimbursement, funding concerns, pharmaceutical policy, cross-national collaboration, european countries

Relation: https://figshare.com/articles/dataset/Table2_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_docx/20077697

الاتاحة: https://doi.org/10.3389/fphar.2022.873556.s003
https://figshare.com/articles/dataset/Table2_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_docx/20077697

المؤلفون: Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, new cancer medicines, patient-level datasets, pricing and reimbursement, funding concerns, pharmaceutical policy, cross-national collaboration, european countries

Relation: https://figshare.com/articles/dataset/DataSheet1_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_pdf/20077691

الاتاحة: https://doi.org/10.3389/fphar.2022.873556.s001
https://figshare.com/articles/dataset/DataSheet1_Challenges_and_Opportunities_With_Routinely_Collected_Data_on_the_Utilization_of_Cancer_Medicines_Perspectives_From_Health_Authority_Personnel_Across_18_European_Countries_pdf/20077691

المؤلفون: Pontes, Caridad, Zara, Corinne, Torrent-Farnell, Josep, Obach, Merce, Nadal, Cristina, Vella-Bonanno, Patricia, Ermisch, Michael, Simoens, Steven, Hauegen, Renata Curi, Gulbinovič, Jolanta, Timoney, Angela, Martin, Antony P, Mueller, Tanja, Nachtnebel, Anna, Campbell, Stephen, Selke, Gisbert, Bochenek, Tomasz, Rothe, Celia C, Mardare, Ileana, Bennie, Marion, Fürst, Jurij, Malmstrom, Rickard E, Godman, Brian

المصدر: Applied health economics and health policy, Cham : Springer International Publishing, 2020, vol. 18, no. 1, p. 5-16 ; eISSN 1179-1896

مصطلحات موضوعية: new cancer medicines, funding, olaratumab, Europe

Relation: http://vu.lvb.lt/VU:ELABAPDB45864751&prefLang=en_US

الاتاحة: http://vu.lvb.lt/VU:ELABAPDB45864751&prefLang=en_US